on dissolution of Solvay Biochemicals (Taixing) Limited amounting to 89 MB from other comprehensive income to the profit of the year 2018. Summary of Performance For the year 2019, the Company and its
Omnichannel platform which is thriving as we attract new customers and welcome back existing ones. After reopening stores, our sales and profit in the third quarter have steadily recovered compared to the last
Company’s auditor. The conclusion was detailed as follows: The Company's operating results and its subsidiaries for the third quarter of 2019, the consolidated financial statements showed the net profit of
Operating Results of the Company in Q3/2019 Q3/18 Q3/19 (THB million) YoY Operating Revenue 287 219 (24%) Gross Profit 188 137 (27%) EBITDA 91 58 (36%) Net Profit for the Company 60 13 (78%) Gross profit
PowerPoint Presentation After You Public Company Limited Management Discussion & Analysis Q3/2020 Management Discussion & Analysis Q3/2020 Gross Profit and Gross Profit Margin • The Company’s gross
% Administrative expenses 130 153 (23) -15.2% Impairment loss in goodwill 53 - 53 100% Profit for the year 225 308 (83) -27% Net loss for the year from discontinued operations. - (8) 8 100% Profit (loss
81.8% to 91.5% that was higher ratio than the increase of selling price. As a result, the company had profit for the period at Baht 9.2 million, a decrease of 80.7 million Baht or 89.8% from the same
434.76 340.81 28 Total Expenses (406.40) (336.74) 20.69 Finance Costs (4.24) (4..62) (8.23) Profit before Income Tax Expenses 24.43 1.48 1,551 Income Tax Expensed (6.77) (0.59) 1,047 Net Profit 17.66 0.89
at the end of Q4/2019, thus the Company expects gross profit margin from sales to get back to a normal level in Q1/2020. • In Q4/2018, there were one-time reversal expenses of Baht 83.9 million from
recurring income. The change in the past 3 years is as follows; Unit : Thousand Baht 1st half 2018 1st half 2017 1st half 2016 Income 85,812 31,519 4,931 Net profit 11,630 4,937 549 From year 2016, the Group